N6-methyladenosine (m6A) Writer WTAP Potentiates Hepatocellular Carcinoma Immune Evasion and Aerobic Glycolysis

Fatao Yu,Yuling Feng,Qing Wang,Jian Sun
DOI: https://doi.org/10.1007/s12013-024-01342-5
2024-06-15
Cell Biochemistry and Biophysics
Abstract:Hepatocellular carcinoma (HCC) is one of most prevalent malignant tumors with poor prognosis and a high mortality rate. Recent research indicates that N 6 -methyladenosine (m 6 A) and tumor immunotherapy are important factors in HCC. More research is still needed to fully understand the profound roles that m 6 A writer Wilms tumor 1-associated protein (WTAP) and CD8 + T cells play in the antitumor immunity that prevents HCC from progressing. According to the findings of our investigation, WTAP was significantly elevated in HCC cells and was associated with a poor prognosis. Functionally, WTAP accelerated HCC immune evasion and aerobic glycolysis while suppressing the tumor-killing ability of CD8 + T cells. On the other hand, WTAP knockdown had the opposite effect. WTAP targets the m 6 A site on the 3'-UTR of PD-L1 mRNA, which mechanistically increases the stability of PD-L1 mRNA. These results showed that WTAP inhibited CD8 + T cells' antitumor activity, which in turn deteriorated HCC immune evasion and aerobic glycolysis. In conclusion, our research uncovers a novel mechanism for WTAP on the tumor-killing ability of CD8 + T cells, which helps to overcome HCC immune evasion.
biochemistry & molecular biology,cell biology,biophysics
What problem does this paper attempt to address?